Mole Check Billing Codes: ICD-10 & CPT

Accurate billing for a mole check requires proper use of ICD-10 diagnosis codes and CPT procedure codes. Whether you are a dermatologist, primary care physician, or billing specialist, understanding the correct codes ensures reimbursement and compliance. This article details the essential ICD-10 codes for mole evaluation and corresponding CPT procedure codes for various clinical scenarios.

A mole check typically involves evaluating skin lesions, documenting findings, and sometimes performing biopsies or excisions. The medical necessity of the visit drives code selection. For routine screening without specific concerns, use preventive medicine codes (99381–99397). However, when the patient presents with a specific mole or lesion, the encounter becomes problem-oriented, and you must use an E/M code plus a diagnosis code that reflects the reason for the visit.

Common ICD-10 codes for a mole check include D22.9 (melanocytic nevus unspecified), L82.1 (seborrheic keratosis), and D48.5 (neoplasm of uncertain behavior of skin). When the patient has a personal history of skin cancer, use Z86.02 (personal history of malignant melanoma) or Z86.03 (personal history of other malignant neoplasm of skin). The appropriate ICD-10 code should always be supported by the documentation.

ICD-10 Codes for Mole Evaluation

When a patient presents for a mole check, the provider must determine the nature of the lesion. Here are the most frequently used ICD-10 codes:

• D22.9 – Melanocytic nevus, unspecified
• D22.0 – Melanocytic nevus of lip
• D22.1 – Melanocytic nevus of eyelid
• D22.2 – Melanocytic nevus of ear and external auricular canal
• D22.3 – Melanocytic nevus of other parts of face
• D22.4 – Melanocytic nevus of scalp and neck
• D22.5 – Melanocytic nevus of trunk
• D22.6 – Melanocytic nevus of upper limb
• D22.7 – Melanocytic nevus of lower limb
• L82.1 – Seborrheic keratosis
• D48.5 – Neoplasm of uncertain behavior of skin
• C43.9 – Malignant melanoma of skin, unspecified (if suspected or confirmed)
• Z86.02 – Personal history of malignant melanoma
• Z86.03 – Personal history of other malignant neoplasm of skin

For routine screening without a specific complaint, use a preventive medicine code (e.g., V70.0 or Z00.00) if no problem is addressed. However, if a mole is examined, you must code the lesion. The ICD-10 code should reflect the diagnosis established during the visit.

CPT Codes for Mole Check Services

The CPT code for a mole check depends on the service provided. For an office visit, use an Evaluation and Management (E/M) code (99202–99215) for a new or established patient. If a procedure is performed, report the appropriate code in addition to the E/M code, using modifier 25 if applicable.

Common procedural codes for mole checks include:

• 11100 – Biopsy of skin, subcutaneous tissue, and/or mucous membrane (single lesion)
• 11101 – Biopsy of skin, subcutaneous tissue, and/or mucous membrane (each separate/additional lesion)
• 17000 – Destruction (e.g., laser, electrosurgery, cryosurgery) of premalignant lesions (e.g., actinic keratosis); first lesion
• 17003 – Destruction of premalignant lesions; second through 14 lesions
• 17250 – Chemical cauterization of granulation tissue (proud flesh)
• 11200 – Removal of skin tags, up to 15 lesions
• 11400–11446 – Excision of benign lesions (includes margins)
• 11600–11646 – Excision of malignant lesions (includes margins)

For a comprehensive mole check without any procedure, use an E/M code only. If a biopsy or destruction is performed, add the procedure code with modifier 25 on the E/M code to indicate that the decision for the procedure was made during the same visit. For example, a new patient with a suspicious mole who undergoes a biopsy may be billed as 99203 (E/M) with modifier 25, plus 11100.

When a patient returns for the results of a biopsy, that is a separate encounter. Typically, you would report an E/M code with the appropriate diagnosis (e.g., the verified pathology code). The CPT code for a follow-up visit is a lower-level E/M code (e.g., 99212 for an established patient).

Documentation is critical. For every mole check, record the medical necessity: why the patient is there (e.g., “concern about changing mole”), what is found (e.g., “asymmetric, irregular border, multiple colors”), and what was done (e.g., “suggested biopsy, patient agreed”). This supports both the ICD-10 code and the procedural code.

Billing Scenarios and Examples

Consider these common scenarios:

• Scenario 1: New patient, age 45, presents for a full skin exam. She has a mole on her back that has been present for years with no change. You document a stable nevus. Code: 99385 (preventive medicine, new patient 40–64) if no problem addressed. If the mole exam is the reason, use 99203 with D22.9.
• Scenario 2: Established patient, age 60, with personal history of melanoma (Z86.02) comes for a routine skin check. You find a seborrheic keratosis on his arm. Code: 99213 with Z86.02 (primary) and L82.1 (secondary).
• Scenario 3: New patient, age 30, concerned about a mole on her leg that has changed. You perform a shave biopsy (11100). Code: 99203 (modifier 25) + 11100 with D48.5 (neoplasm uncertain behavior) or D22.6 (if benign). Later, pathology reveals melanoma (C43.7). You need to update the diagnosis to C43.7 and possibly resubmit.

Always remember that proper use of the correct ICD-10 and CPT code combinations ensures accurate reimbursement and reduces audit risk. Keep abreast of payer-specific guidelines and medical necessity requirements.

In conclusion, billing for a mole check involves selecting the correct diagnosis code that reflects the nature of the lesion (benign, malignant, uncertain, or personal history) and the appropriate procedure code if an intervention occurred. The evaluation and management code must match the level of history, exam, and medical decision making documented. By following these guidelines, you can confidently code for mole checks and optimize revenue while maintaining compliance.

For further reference, the American Academy of Dermatology provides coding resources, and CMS publishes the National Correct Coding Initiative (NCCI) edits to prevent unbundling. Also, remember that the ICD-10 code should be the most specific code available; use the laterality and location when applicable (e.g., D22.61 for upper limb, left).

With the rise of telemedicine, mole checks via telehealth have become popular. For audio-video visits, use the appropriate telehealth E/M codes (e.g., 99202–99215 with modifier 95 or GT modifier). The CPT code for a telehealth visit is the same as for in-person, but the diagnosis must still be supported. Ensure that the technology meets HIPAA standards and that the patient has consented to telehealth.

Finally, document all conversations with patients about suspicious lesions, even if no procedure is performed. The medical record should clearly show that the patient was educated about the ABCD(E) signs of melanoma and the plan for future surveillance. This not only supports coding but also improves patient outcomes.